Lessons on haemopoietic Stem cell transplantation

ESH eLearning, Robert Gale, 165972

Conditioning regimens: reduced intensity versus myeloablative

ESH eLearning, Annalisa Ruggeri, 165973

Matched unrelated donors

ESH eLearning, Andrea Bacigalupo, 165974

Unrelated cord blood

ESH eLearning, eliane Gluckman, 165975

Related haplo mismatched with post-transplant cyclophosphamide

ESH eLearning, Andrea Bacigalupo, 165976

Myeloproliferative disorders

ESH eLearning, Nicolaus Kröger, 165988

Aggressive non Hodgkin lymphoma

ESH eLearning, Peter Dreger, 165989

Adults acute leukaemia (AML and ALL)

ESH eLearning, Sebastian Giebel, 165990

Immune reconstitution and tolerance

ESH eLearning, Francesco Dazzi, 165991

Prevention and treatment of relapse

ESH eLearning, Francesco Dazzi, 165992

Closing remarks

ESH eLearning, Joan-LLuis Vives-Corrons, 119645

New treatments of dyserythropoiesis

ESH eLearning, Jean-Benoit Arlet, 119644

New treatments of PKD

ESH eLearning, Ann Barbier, 119643

Gene therapy for PKD and other rare disorders

ESH eLearning, Jose Segovia, 119642

Paroxysmal nocturnal haemoglobinuriaClinical picture, underlying mechanisms, laboratory diagnosis

ESH eLearning, Antonio M. Risitano, 119641

Microangiopathic haemolytic anemias TTP, HUS (haemolytic uraemic syndrome)

ESH eLearning, Flora Peyvandi, 119640

Transient and chronic cold-antibody mediated haemolyticanaemia

ESH eLearning, Sigbjorn Berentsen, 119639

Autoimmune haemolytic anaemias by warm antibodies

ESH eLearning, Wilma Barcellini, 119638

Red blood cell enzymes abnormalities

ESH eLearning, Paola Bianchi, 119637

Erythropoietic porphyrias

ESH eLearning, Maria Domenica Cappellini, 119636

Hereditary stomatocytosis

ESH eLearning, loic garcon, 119635

Hereditary elliptocytosis, pyropoikilocytosis and South-east Asian ovalocytosis

ESH eLearning, tabita maia, 119634

Disorders of RBC cytoskeleton: hereditary spherocytosis

ESH eLearning, Paola Bianchi, 119633

Hereditary sideroblastic anaemiasPathophysiology, genetics, clinical, information,Laboratory investigations including rational step of diagnosis

ESH eLearning, Reinier Raymakers, 119632

Hereditary microcytic anaemia - Molecular basis,clinical presentation and management.

ESH eLearning, achille iolascon, 119631

Crosstalk between iron and erythropoiesis:a lesson from IRIDA

ESH eLearning, Laura Silvestri, 119630

Aplastic anaemia

ESH eLearning, Antonio M. Risitano, 119629

Diamond blackfan anaemia

ESH eLearning, Lydie Da Costa, 119628

Congenital dyserythropoietic anaemias (CDA)

ESH eLearning, achille iolascon, 119627

An overwiew on the epidemiology of very rare anaemiasData from the ENERCA project ? The role of registries

ESH eLearning, Michael Angastiniotis, 119626

Introduction

ESH eLearning, Patricia Aguilar-Martinez, 119625

The niche concept

ESH eLearning, Toshio Suda, 165658

Effect of aging on tumor microenvironment

ESH eLearning, Hartmut Geiger, 165659

Dynamic interactions between normal and malignant haematopoietic cells and their niches

ESH eLearning, Cristina Lo Celso, 165660

A systems biological perspective on stem cell / niche interactions

ESH eLearning, Ingo Roeder, 165661

Moving LSC out of the niche

ESH eLearning, Amnon Peled, 165662

Modulation of the bone marrow microenvironment by PTH for improvement of therapy for CML

ESH eLearning, Daniela Krause, 165663

Microenvironment in B cell lymphoma

ESH eLearning, Jianguo Tao, 165664

Access ITP Curriculum

ESH eLearning, ESH , 170302

Diagnosis

ESH eLearning, Anna v, 165443

Prognosis

ESH eLearning, Raphaël Itzykson, 165444

Treatment of lower risk MDS (non del 5q)

ESH eLearning, Eva Hellstrom-Lindberg, 165445

Allogeneic SCT

ESH eLearning, Nicolaus Kröger, 165446

Overview of new drugs, clinical trials, and international cooperative efforts in clinical research

ESH eLearning, Pierre Fenaux, 165447

Molecularly defined MDS and MDS/MPN

ESH eLearning, Pierre Fenaux, 165448

Do we need a different niche for fast haematopoietic reconstitution in cord blood transplantation?

ESH eLearning, G. Koegler, 165498

Emergence of fetal immune-restricted lympho-myeloid progenitors prior to definitive haematopoietic stem cells

ESH eLearning, S.E. Jacobsen, 165499

Cord blood stem cells acquire the signature of induced pluripotent stem cells (iPS) when transplanted

ESH eLearning, F. Frassoni, 165500

Nicord expands haematopoietic stem cells and shortens time to engraftment in patients undergoing cord blood transplantation for haematological malignancies and sickle cell disease

ESH eLearning, J. Kurtzberg, 165501

Rescue of the mucocutaneous manifestations in a mouse model of recessive dystrophic epidermolysis bullosa (RDEB) by human cord blood (CB) derived unrestricted somatic stem cells (USSCS)

ESH eLearning, M. Cairo, 165502

History and future of cord blood transplantation

ESH eLearning, E. Gluckman, 165503

Single versus double cord blood transplant in children

ESH eLearning, J. Wagner, 165504

Introduction of the Cord Blood Bank Technology Survey (WMDA-NetCord)

ESH eLearning, E. Baudoux, 165505

Cost efficiency of cord blood banks

ESH eLearning, S. Querol, 165506

Contribution of Eurocord registry to the improvement of cord blood banking

ESH eLearning, I. Ionescu, 165507

State of the art

ESH eLearning, E. Petersdorf, 165508

Analysis of classical HLA haplotypes can predict outcomes of haematopoietic stem cell transplantation

ESH eLearning, R. Tamouza, 165509

IRES: an immune reconstitution study of umbilical cord blood transplant recipients

ESH eLearning, J. Girdlestone, 165510

Importance of CD4+ lymphocyte reconstitution following cord blood transplantation

ESH eLearning, P. Veys, 165511

Towards individualized conditioning regimens to improve the outcomes of cord blood transplantation

ESH eLearning, J. Boelens, 165512

How to improve cord blood transplant results in adults

ESH eLearning, J. Sanz, 165513

Prevention of GVHD by umbilical cord blood derived T- regulatory cells

ESH eLearning, J. Wagner, 165514

Prospective study on allogeneic transplant in acute myeloid leukaemia according to the policy of the Rome Transplant network for donor selection: HLA identical sibling vs matched unrelated vs haploidentical related donor

ESH eLearning, W. Arcese, 165515

Assessment of adhesion and homing molecules alteration in ex vivo expansion of umbilical cord blood CD34+ haematopoietic stem cells

ESH eLearning, M. N. Zarif, 165516

Comparison of HLA-G expression in mesenchymal stromal cells derived from bone marrow, placenta, umbilical cord and amniotic membrane

ESH eLearning, M. N. Zarif, 165517

Inventory depuration

ESH eLearning, L. Ponce-Verdugo, 165518

Clinical utility of family-directed cord blood storage

ESH eLearning, M. Abecasis, 165519

Clinical utility of family-directed cord blood storage

ESH eLearning, M. Abecasis, 165520

Comparison of the results of haemoglobin pattern screened in different public health services: umbilical cord blood bank of the Hospital de Clínicas de Porto Alegre (BSCUP-HCPA) and newborn screening reference service of Rio Grande Do Sul (SRTN-RS), Brazil

ESH eLearning, L.M. Röhsig, 165521

Substantially reduced red cell contamination with comparative nucleated cell recovery using sample specific red cell depletion and plasma reduction technique (a retrospective analysis of 9637 umbilical cord blood units at LifeCell International, India)

ESH eLearning, P. Dhot, 165522

Umbilical cord blood collection: first year operations at the Canadian Blood Services, National Public Cord Blood Bank

ESH eLearning, H. Elmoazzen, 165523

Treatment of sickle cell disease in emerging countries

ESH eLearning, M. de Montalembert, 165524

Indication of bone marrow transplantation in sickle cell disease

ESH eLearning, F. Bernaudin, 165525

International survey of haematopoietic stem cell transplant from an HLA identical sibling for sickle cell disease

ESH eLearning, B. Cappelli, 165526

Establishing a cost-effective national cord blood registry in a resource restricted environment

ESH eLearning, S. Narayan, 165527

A potential treatment for beta-thalassemia and sickle cell disease via high-efficiency targeted genome editing of hematopoietic stem cells

ESH eLearning, M. Walters, 165528

Gene therapy for hereditary disorders

ESH eLearning, J.A Ribeil, 165529

Indications and results of the use of stem cells for regenerative medicine

ESH eLearning, G. Koegler, 165530

The red cell: from genesis to death

ESH eLearning, Oliver Hermine, 95254

Closing debate

ESH eLearning, Dr. Martin Colard and Dr. Corentin Orvain, 95402

Closing debate: The future of red cell pathologies among (European) medical professionals: are there new young haematologists in this field?

ESH eLearning, Dimitris Loukopoulos, 95017

Iron overload in thalassaemia and sickle cell disease

ESH eLearning, Maria Domenica Cappellini, 95015

Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications

ESH eLearning, Oliver Hermine, 95253

Gene therapy in thalassaemia and sickle cell disease

ESH eLearning, Yves Beuzard, 95014

Bone marrow transplantation in thalassaemia and sickle cell disease, including haploidentical BMT

ESH eLearning, Alina Ferster, 95013

Guidelines for the biological diagnosis of haemoglobinopathies

ESH eLearning, C.L. Harteveld, 95012

Unstable haemoglobins: Physiopathology, clinical and biological diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95011

Laboratory diagnosis of abnormal haemoglobins, an update - From phenotype to genotype

ESH eLearning, Frederic Cotton, 95016

Sickle cell disease in adults and elderly patients: Emerging complications and management

ESH eLearning, Lucia De Franceschi, 95010

Sickle cell disease (SCD) in children and adolescents

ESH eLearning, Mariane de Montalembert, 95009

Alpha-thalassaemia: new fast test for the molecular diagnosis

ESH eLearning, C.L. Harteveld, 95008

Beta-thalassaemia: from CBC to DNA: methodologies and laboratory diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95007

Beta-thalassaemia: clinical findings, molecular defects genotype / phenotype relationship

ESH eLearning, Maria Domenica Cappellini, 95005

Recommendations for the recognition of centres of expertise on haemoglobinopathies in Europe

ESH eLearning, Joan-LLuis Vives-Corrons, 95004

Prevention programmes for thalassaemia and sickle cell disease: past and present

ESH eLearning, Michael Angastiniotis, 95003

Prevention of severe forms of haemoglobinopathies: Newmethodologies and procedures

ESH eLearning, Marina Kleanthous, 95001

Neonatal screening for sickle cell disease in European countries: where are we in 2015?

ESH eLearning, BEATRICE GULBIS, 95000

Migrations and haemoglobin disorders: current status in European countries

ESH eLearning, Maria del Mar MANU (Mañú), 94999

Introduction to the course

ESH eLearning, Patricia Aguilar-Martinez, 95252